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Ischemic conditioning is defined as a transient and subcritical period of ischemia
integrated in an experimental paradigm that involves a stimulus of injurious ischemia,
activating endogenous tissue repair mechanisms that lead to cellular protection under
pathological conditions like stroke. Whereas ischemic pre-conditioning is irrelevant
for stroke treatment, ischemic post-conditioning, and especially non-invasive remote
ischemic post-conditioning (rPostC) is an innovative and potential strategy for stroke
treatment. Although rPostC has been shown to induce neuroprotection in stroke models
before, resulting in some clinical trials on the way, fundamental questions with regard
to its therapeutic time frame and its underlying mechanisms remain elusive. Hence,
we herein used a model of non-invasive rPostC of hind limbs after cerebral ischemia
in male C57BL6 mice, studying the optimal timing for the application of rPostC and
its underlying mechanisms for up to 3 months. Mice undergoing rPostC underwent
three different paradigms, starting with the first cycle of rPostC 12 h, 24 h, or 5 days
after stroke induction, which is a very delayed time point of rPostC that has not been
studied elsewhere. rPostC as applied within 24 h post-stroke induces reduction of infarct
volume on day three. On the contrary, very delayed rPostC does not yield reduction of
infarct volume on day seven when first applied on day five, albeit long-term brain injury
is significantly reduced. Likewise, very delayed rPostC yields sustained neurological
recovery, whereas early rPostC (i.e., <24 h) results in transient neuroprotection only.
The latter is mediated via heat shock protein 70 that is a well-known signaling protein
involved in the pathophysiological cellular cascade of cerebral ischemia, leading to
decreased proteasomal activity and decreased post-stroke inflammation. Very delayed
rPostC on day five, however, induces a pleiotropic effect, among which a stimulation of
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angioneurogenesis, a modulation of the ischemic extracellular milieu, and a reversal of
the stroke-induced immunosuppression occur. As such, very delayed rPostC appears to
be an attractive tool for future adjuvant stroke treatment that deserves further preclinical
attention before large clinical trials are in order, which so far have predominantly focused
on early rPostC only.
Keywords: focal cerebral ischemia, remote ischemic post-conditioning, neuroprotection, neuroregeneration,
immune response, proteasome
INTRODUCTION
With the recent success of endovascular strategies to avoid
stroke induced brain injury (Campbell et al., 2015; Goyal et al.,
2015), treatment paradigms for stroke patients have significantly
changed. Nevertheless, restricted eligibility of patients for both
endovascular treatment and especially systemic thrombolysis
requests for novel adjuvant treatment paradigms (Lees et al.,
2010). In this context, enhancing the endogenous resistance
and regenerative capacity of the ischemic brain appears to
be very attractive, thus avoiding the need of neuroprotective
drug delivery or stem cell transplantation, to name but a few
experimental concepts.
Ischemic conditioning is an experimental strategy that has
been studied for decades, using a variety of animal models
including but not limited to stroke models (Zhang et al., 2003;
Ding et al., 2004; Gidday, 2006; Davis et al., 2007; Xie et al., 2013;
Badawi et al., 2015). As such, ischemic conditioning is defined
as a transient and subcritical period of ischemia embedded
in an experimental setup where ischemic conditioning can be
induced before (pre-conditioning), during (per-conditioning) or
after (post-conditioning) injurious ischemia. Although studies
on ischemic pre-conditioning in stroke models have given new
insights into the pathogenesis of stroke, involving a plethora of
signaling molecules such as the nuclear factor (NF)-κB, hypoxia-
inducible factor (HIF)-1α, tumor necrosis factor (TNF)-α, and
inducible NO synthase (iNOS) (Gidday, 2006; Garcia-Bonilla
et al., 2014), ischemic pre-conditioning is irrelevant from a
therapeutic point of view. The scientific focus has therefore
switched from ischemic pre-conditioning toward ischemic post-
conditioning of the brain.
To this date, ischemic post-conditioning has been shown to be
neuroprotective in a variety of experimental stroke models (Gao
et al., 2008; Xing et al., 2008; Anrather and Hallenbeck, 2013;
Xie et al., 2013), albeit precise signaling cascades involved in this
neuroprotective process have not been shown for the majority
of studies. Recently, our group has not only demonstrated
that direct ischemic post-conditioning is neuroprotective in a
model of transient focal cerebral ischemia in mice, but also
that ischemic post-conditioning facilitates transplantation of
neural progenitor cells (NPCs) leading to sustained neurological
recovery (Doeppner et al., 2017). The latter is a consequence
of pleiotropic mechanisms, among which stabilization of the
blood-brain barrier, reduction of leukocyte infiltration into the
brain, and reduction of oxidative stress levels play pivotal roles.
Despite positive proof-of-concept studies on cerebral ischemic
post-conditioning, the latter are unlikely to be translated into a
real world clinical setting which would then imply induction of a
second subsequent cerebral ischemia in acute stroke patients.
Whereas immediate ischemic post-conditioning of the brain
itself is impractical in clinical settings for obvious reasons,
the concept of remote ischemic post-conditioning (rPostC) has
gained a substantial amount of attraction. Indeed, rPostC in
general and hind limb rPostC in particular has been shown to
be neuroprotective, albeit survival periods of these studies did
not extend 2 weeks, giving insights in some underlying cellular
signaling pathways only (Hasseldam et al., 2013; Li S. et al., 2015;
Ren et al., 2015, 2018; Ramagiri and Taliyan, 2017a,b). Although
first clinical trials with regard to rPostC in stroke-like settings are
underway with indication of both a putative beneficial effect and
safety (Hou et al., 2016; England et al., 2017; Wang et al., 2017;
Zhao et al., 2017), further pre-clinical studies are urgently needed
in order to address fundamental issues. As a matter of fact, the
RECAST trial remains the only trial using rPostC as a tool for
acute stroke treatment, whereas other trials focus on the impact
of rPostC on conditions of chronic vessel disease only. Using
a model of transient focal cerebral ischemia in mice followed
by hind limb rPostC, the present study therefore addresses the
therapeutic time window of rPostC beyond application time
points of 24 h and further elucidates cellular mechanisms being
involved in the process.
MATERIALS AND METHODS
Experimental Animals and Induction of
Transient Focal Cerebral Ischemia in
Mice
All experiments were carried out according to the guidelines
for the care and health of animals and were approved
by local authorities. Experimental procedures followed the
ARRIVE recommendations. Mice were randomly allocated to
the experimental treatment groups. Surgeons and analysts
were different from each other so that analysts were blinded
to the treatment paradigms. Survival periods are given in
Supplementary Table S1.
Male C57BL6 mice (24–28 g) were exposed to 60 min of
middle cerebral artery occlusion (MCAO) as previously described
(Doeppner et al., 2017), followed by a reperfusion period for
a maximum of 84 days. Briefly, mice received anesthesia with
1.5% isoflurane and underwent midline neck incision. The left
common carotid artery (CCA) was prepared and after incision,
a silicon-coated nylon monofilament (Doccol, United States) was
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gently inserted into the left CCA, which was then pushed forward
through the internal carotid artery (ICA), reaching the proximal
branch of the left middle cerebral artery (MCA). Once there, the
filament was left in situ for 60 min under constant laser Doppler
flow control. The body temperature was continuously measured
using a rectal feedback probe and a heating pad, keeping the
body temperature between 36.5◦C and 37◦C. Consequently, this
setting allows for brain infarcts affecting the striatum and part of
the cortex.
Induction of rPostC and Experimental
Groups
Induction of rPostC was essentially performed as previously
described with some modifications (Ramagiri and Taliyan,
2017b). Non-invasive, rPostC was done using tourniquets for
induction of transient ischemia of both hind legs. A complete
cycle of rPostC consisted of three periods of a 10-min ischemia
interrupted by 10 min of reperfusion of both hind legs. The
experimental protocol of rPostC differed, depending on the
survival periods of the animals. Mice that survived for 3 or 7 days,
received their first rPostC at the time points given, i.e., at 12 h, at
24 h or at 120 h, followed by additional cycles of rPostC on each
consecutive day until the time of sacrifice. For survival periods
of 3 months, rPostC started at the time points given and was
continued until day two (beginning of rPostC 12 h and 24 h
only), whereas mice receiving their first cycle of rPostC on day
five received additional cycles of rPostC on each consecutive day
until day 14. For details please refer to Supplementary Figure S1.
Analysis of Post-Ischemic Brain Injury
Brain injury at acute and subacute time points was assessed
using triphenyltetrazolium chloride (TTC) staining on 2-mm-
thick brain slices. In these slices, infarct volume was outlined
and brain edema was calculated as relative increase of the
ipsilateral compared to contralateral hemispheric volume. For
long-term assessment of brain injury, animals were sacrificed
on day 84 after MCAO for which mice were transcardially
perfused with 4 % paraformaldehyde in 0.1 M phosphate-
buffered saline (PBS). Thereafter, brains were removed, and
20 µm coronal cryostat sections were collected. The latter were
used for immunohistochemistry for the neuronal marker NeuN,
which was detected by a monoclonal mouse anti-NeuN antibody
(1:1000; Millipore, United Kingdom). Quantitative analysis of the
density of surviving neurons in the ischemic striatum was done
within four regions of interest in three sections per animal at
AP+ 0.14mm,ML± 1.5–2.25mm, andDV−2.5–3.25mm from
bregma.
Analysis of Post-Stroke
Neuroregeneration
Neuroregeneration as indicated herein by endogenous
neurogenesis and angiogenesis, was analyzed 3 months after
stroke induction. As such, mice received intraperitoneal
injections of bromodeoxyuridine (50 mg/kg, Sigma-Aldrich,
Germany) on days 8–28. Following transcardial perfusion
with 4% paraformaldehyde in 0.1 M PBS on day 84,
immunohistochemical analysis was performed in coronal
cryostat sections using the following primary antibodies:
monoclonal mouse anti-BrdU (1:400; Roche, Germany),
monoclonal rat anti-BrdU (1:400; Abcam, United Kingdom),
polyclonal goat anti-doublecortin (Dcx; 1:50; Santa Cruz
Biotechnology) and monoclonal mouse anti-NeuN (1:1000;
Millipore) and monoclonal rat anti-CD31 (1:200, BD
Biosciences, Germany). Following detection with appropriate
secondary antibodies, the density of proliferating BrdU+
cells, BrdU+/Dcx+ neurons, BrdU+/NeuN+ neurons, and
BrdU+/CD31+ endothelial cells was evaluated as described for
NeuN immunohistochemistry using the same coordinates and
regions of interest.
Assessment of Post-Stroke Neurological
Recovery
All mice received training 1–2 days before MCAO in order to
ensure proper test performance in the rota rod test, the tight
rope test, the corner turn test, and the balance beam test. These
tests were performed as previously described (Doeppner et al.,
2014a). The rota rod test, the tight rope test, and the balance
beam test were performed in duplicates per test day from which
means were calculated. Readout in the rota rod test was the time
until the animal dropped off the rotating drum with a maximal
testing time of 300 s, whereas in the tight rope test the time
until the animal reached the platform was assessed (maximal
testing time 60 s). Test scores in the tight rope test ranged from 0
(minimum) to 20 (maximum). The balance beam test measured
the time the animal needed to reach the platform by crossing a
horizontal beam with continuously narrowing width (maximal
testing time 60 s). In the corner turn test, the laterality index
was calculated out of 10 trials per test day, with a score of 0.5
indicating no neurological impairment and a score of 1 indicating
severe neurological impairment.
Knockdown of Hsp70
For some experiments, stereotactic injections prior to induction
of MCAO were performed in order to evaluate whether or not
Hsp70 is involved in the aforementioned neuroprotection on
day 3 induced by rPostC. As such, Hsp70 was knocked down
using an Accell SMARTpool mouse Hsp70 small interfering
RNA (siRNA) (4 mg/kg body weight; Dharmacon, Germany),
which was intracerebrally administered into the striatum 3 days
before stroke as previously described (Doeppner et al., 2012b).
For control, mice received Accell non-targeting small interfering
RNA (4 mg/kg body weight; Dharmacon) injections. Thereafter,
rPostC was induced as explained afore, i.e., starting either 12 h or
24 h after stroke. Infarct volume analysis using TTC staining was
performed on day 3 after MCAO.
Measurement of Proteasome Activity
Assessment of proteasome activity was performed as described
previously (Doeppner et al., 2012b). Briefly, proteasome
activity was measured in brain homogenates of left (ischemic)
hemispheres 72 h post-stroke using lysis buffer (100 mM
Tris-Hcl, 145 mM NaCl, 10 mM EDTA, and 0.5% Triton X-100
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at pH 7.5). The chymotrypsin-like activity of the proteasome
was measured using Suc-LLVY-AMC (50 µM; Sigma-Aldrich,
Germany) as a substrate that was incubated with 90µl of reaction
buffer containing 50 mM Tris, 20 mM KCl, 1 mM magnesium
acetate, 2 mM dithiothreitol (DTT), 1 mM leupeptin, 1 µg/ml
aprotinin (Sigma-Aldrich) and 1 mM PMSF (Merck, Germany).
The extent of substrate cleavage was evaluated at 37◦C in a
fluorescence microtiter plate reader at λexc. = 355 nm and at
λem. = 460 nm. Since Suc-LLVY is not exclusively cleaved by the
proteasome, specificity was increased by adding the proteasome
inhibitor MG-132 (1 mM; Sigma-Aldrich, Germany) at the
beginning of the measurement. Proteasome activities were given
as arbitrary units per min per mg protein. Protein concentration
was measured using the Bradford assay.
Growth Factor Measurements
The concentration of brain-derived neurotrophic factor (BDNF;
Promega, Germany), glial cell line-derived neurotrophic factor
(GDNF, Promega), vascular endothelial growth factor (VEGF;
R&D Systems, United States), nerve growth factor (NGF;
Promega), basic fibroblast growth factor (bFGF; R&D Systems)
and epidermal growth factor (EGF; R&D Systems) was measured
by enzyme linked immunosorbent assay (ELISA) in left
(ischemic) hemispheres 84 days after MCAO as described before
(Doeppner et al., 2012a).
Analysis of Post-Stroke Inflammatory
Responses
Flow cytometry analysis was performed on day 7 in order to
assess post-ischemic immune responses both in the brain and in
the blood as previously described (Chu et al., 2014; Doeppner
et al., 2014b, 2015). Briefly, for analysis of blood samples,
leukocytes were purified using lysis buffer consisting of 155 mM
NH4Cl, 10 mM KHCO3 and 3 mM EDTA. For flow cytometry
measurements of brain tissue samples, ischemic left hemispheres
were mechanically homogenized in a buffer of collagenase
type XI (125 U/ml), hyaluronidase (60 U/ml) and collagenase
FIGURE 2 | Sustained neuroprotection is a consequence of very delayed
rPostC only. Long-term neuroprotection was analyzed using determination of
neuronal density on day 84 after stroke induction as described in the materials
and methods section. Time points given refer to the induction of rPostC,
whereas control animals did not receive rPostC (Non-PostC). Data is given as
mean ± standard deviation with ∗ indicating statistical significance compared
to both Non-PostC and other rPostC groups (p < 0.05).
(450 U/ml) in Ca2+/Mg2+ supplemented PBS (Sigma-Aldrich,
Germany). Samples were incubated with the antibody in question
as described afore (Doeppner et al., 2015). Absolute cell numbers
were measured using CountBright counting beads (Invitrogen,
United States).
Statistics
All data are given as mean ± standard deviation (SD). For
comparisons between two groups, statistical comparisons were
done using the Student t tests. For comparison between multiple
groups, a one-way ANOVA followed by the Tukey’s post hoc
test was used. P-values < 0.05 were considered to be statistically
significant.
FIGURE 1 | Remote post-conditioning (rPostC) induces acute neuroprotection when applied within 24 h post-stroke. rPostC was induced at 12 h (A), at 24 h (B), or
at 120 h (C) after stroke, using the experimental protocol given in the materials and methods section. Analysis of infarct volumes is given for control animals
(Non-PostC) and treated mice (PostC) using TTC staining on day 3 (A,B) and on day 7. Representative TTC stainings are given for groups using the 24 h
experimental paradigm (B). Data is given as mean ± standard deviation with ∗ indicating statistical significance (p < 0.05).
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RESULTS
Post-Stroke Neuroprotection by rPostC
Depends on Delivery Timing
Experimental stroke paradigms analyzing the effect of rPostC
on brain injury are usually restricted, as they apply one
experimental paradigm with observation periods no longer
than 2 weeks only. Hence, we systematically analyzed three
different experimental paradigms that differed between the start
of the first induction of rPostC. Indeed, early rPostC reduces
infarct volumes 3 days after stroke when applied within 24 h
after stroke onset (Figures 1A,B). The reduction of infarct
volume after rPostC was profound and significant, i.e., infarct
volumes were reduced by 39.8% (rPostC 12 h) and by 26%
(rPostC 24 h), respectively. However, very delayed rPostC failed
to reduce infarct volumes on day seven as applied 120 h
after stroke onset (Figure 1C). Taking into account that the
pathophysiology of stroke involves the development of secondary
cell death, thus leading to the development of further brain
injury even beyond acute and subacute stages of the disease,
brain injury was analyzed 3 months after stroke induction as
well. Interestingly, initial neuroprotection after early rPostC
within 24 h after stroke onset (Figures 1A,B) was lost in the
long run, i.e., neuronal density did not differ between controls
and mice treated with rPostC in these groups (Figure 2). On
the contrary, mice that were exposed to very delayed PostC
120 h after stroke induction showed sustained neuroprotection
(Figure 2), albeit these mice did not show signs of subacute
neuroprotection (Figure 1C). En detail, rPostC initiated at 120 h
increased neuronal density by 60.1% 3 months after stroke
induction.
Sustained Neuroprotection due to Very
Delayed rPostC Is Associated With
Better Neurological Recovery
Induction of early rPostC during the acute phase of the
disease, i.e., 12 and 24 h after stroke onset, yields transient
neuroprotection only that is lost during the observation period of
3 months (Figures 1, 2). Likewise, mice treated with early rPostC
show a transient improvement of neurological recovery in the
four behavioral tests only at the early stage of the disease (data not
shown). In contrast to that, the aforementioned animals did not
develop better test performance in the rota rod, the tight rope, the
corner turn or the balance beam test (Figure 3). Mice that were
treated with very delayed rPostC starting 120 h after stroke onset,
however, gradually improved in the four behavioral tests during
the observation period of 3 months (Figure 3). Consequently,
very delayed rPostC induces sustained and increased neurological
recovery, whereas early rPostC induces transient neurological
recovery only.
Neuroprotection Upon Induction of Early
rPostC Involves Both Proteasomal and
Heat Shock Protein 70 (Hsp70) Cell
Signaling
The pathophysiology of stroke involves inflammatory signaling
cascades (Dirnagl et al., 1999), such as heat shock proteins that act
FIGURE 3 | Sustained neurological recovery is achieved by very delayed rPostC only. Four different behavioral tests were used in order to assess post-stroke
neurological outcome. These tests include the rota rod test (A), the tight rope test (B), the corner turn test (C), and the balance beam test (D). All animals were
trained before induction of transient focal cerebral ischemia in order to ensure proper test performance at the time points given. rPostC was induced at 12 h, at 24 h,
or at 120 h. Non-PostC mice did not receive post-stroke rPostC. Data is given as mean ± standard deviation with ∗ indicating statistical significance compared to
both Non-PostC and other rPostC groups (p < 0.05).
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as physiological ligands of toll-like-receptors (TLR) that regulate
pro-inflammatory signaling cascades including the ubiquitin-
proteasome-pathway (Vabulas et al., 2002; Asea, 2008; Tamura
et al., 2012; Napetschnig and Wu, 2013). Whereas previous
data has described a role for TLR being involved in ischemic
post-conditioning, a role for Hsp70 in direct cerebral post-
conditioning has recently been shown by our group for the very
first time (Feng et al., 2011; Wang et al., 2014; Doeppner et al.,
2017). Herein, we demonstrate that Hsp70 is critically involved
in mechanisms underlying rPostC after focal cerebral ischemia
as well. Knocking down of Hsp70 by means of siRNA constructs
that had been injected 3 days before induction of stroke with
subsequent rPostC, infarct volumes were significantly increased
on day 3 post-stroke when compared to mice that had received
control non-targeting siRNA constructs (Figure 4A). As such,
infarct volumes were increased by 100.8% (induction of rPostC
at 12 h) and by 147.0%, respectively.
Along with the aforementioned role of Hsp70 in the
herein used experimental paradigm, proteasomal activity was
significantly altered by induction of early rPostC (Figure 4B).
As such, induction of early rPostC significantly reduced the
chymotrypsine-like activity of the proteasome in comparison to
mice that were not treated with rPostC. This data suggests that
inhibition of the proteasome might be one factor, leading to
rPostC-induced neuroprotection.
Very Delayed Induction of rPostC
Induces Increased Post-Stroke
Neuroregeneration and Modification of
the Post-Stroke Extracellular Milieu
In contrast to early rPostC, very delayed rPostC induces
sustained neurological recovery and long-term neuroprotection
without being neuroprotective at subacute stages of the disease
(Figures 1, 2), suggesting different mechanisms being involved
depending on the timing of induction of rPostC. As such,
we next addressed the question whether or not very delayed
rPostC affects endogenous neurogenesis, which is known
to persist in the adult mammalian brain as well (Alvarez-
Buylla and Garcia-Verdugo, 2002). Indeed, induction of very
delayed rPostC resulted in significantly increased numbers
of BrdU+ proliferating cells within the ischemic hemisphere
(Figures 5A,D-F). Likewise, an analysis of co-expression patterns
of these BrdU+ cells revealed that rPostC yielded increased co-
expression of BrdU+ cells with both the endothelial marker CD31
and the immature neuronal marker Dcx 3 months after stroke
(Figures 5B,C,G-N).
Angiogenesis and neurogenesis are not independent from
each other, but rather mutually affect each other (Hermann
and Chopp, 2012), and stroke itself stimulates endogenous
neurogenesis (Arvidsson et al., 2002), albeit the majority of new-
born cells is not integrated in residing neural networks but
undergoes secondary cell death (Doeppner et al., 2012a). In
this context, increased numbers of immature neuronal cells co-
expressing BrdU and Dcx after rPostC (Figures 5C,G-J) with
no relevant co-expression of BrdU and the mature neuronal
marker NeuN (0.45 ± 0.08% for Non-rPostC vs. 0.38 ± 0.19%
FIGURE 4 | Acute neuroprotection upon rPostC involves the
Hsp70-proteasome pathway. (A) Mice received stereotactic injections in the
future ischemic striatum 3 days before induction of stroke. Injections either
contained an Accell SMARTpool mouse Hsp70 small interfering RNA (rPostC
Hsp70-k.d.) or an Accell non-targeting small interfering RNA (rPostC Control).
Thereafter, animals underwent induction of stroke followed by exposure to
rPostC at 12 h or at 24 h post-stroke. Infarct volume analysis was done
3 days after stroke induction using TTC staining. (B) Determination of
proteasomal chymotrypsin-like activity from brain lysates of the ischemic
hemisphere 3 days after stroke using Suc-LLVY-AMC as substrate.
Suc-LLVY-AMC is not a specific proteasome substrate. Therefore, some
samples were incubated with the proteasome inhibitor MG-132 (1 mmol/L)
immediately before the measurement in order to ensure recording of
proteasomal activity. Data are given as arbitrary fluorescence units per minute
per mg of total protein. ∗Significantly different (p < 0.05).
for rPostC started at 120 h) is in line with previous observations.
Rather, the aforementioned neuroprotection and neurological
recovery observed after late rPostC is a consequence of indirect
effects of new-born cells. NPCs and derivatives of them act like
“mini pumps,” constantly secreting growth factors and other
mediators, thus affecting their extracellular milieu (Doeppner
et al., 2012a). Indeed, induction of very delayed rPostC resulted
in significantly increased concentration of growth factors such
as VEGF and BDNF, which were increased by 172 % (BDNF)
and by 147.8% (VEGF), 3 months after stroke induction
(Figure 6).
Very Delayed rPostC Reverses
Post-Stroke Immunosuppression
Very delayed rPostC affects post-stroke neuroregeneration and
modulates the extracellular milieu (Figures 5, 6). However, stroke
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FIGURE 5 | Very delayed rPostC is associated with increased neuroregeneration. Quantitative analyses of bromodeoxyuridine positive (BrdU+) proliferating cells (A)
as well as the relative co-expression of the endothelial marker CD31 (B) and the immature neuronal marker Dcx (C) on day 84 in ischemic mice that were exposed to
rPostC 120 h after stroke induction. Mice that were not exposed to rPostC (Non-PostC) served as control. Representative photos taken from within the ischemic
lesion site for BrdU staining (D–F), Dcx staining (G–J) and CD31 staining (K–N). Scale bars: 100 µm. ∗Significantly different from Non-PostC, (p < 0.05).
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FIGURE 6 | Very delayed rPostC modifies the post-stroke extracellular milieu.
The concentration of selected growth factors was measured in ischemic
hemispheres on day 84 post-stroke. Mice were exposed to rPostC at 120 h
after stroke induction with mice receiving no rPostC (Non-PostC) serving as
controls. ∗Significantly different from Non-PostC (p < 0.05).
implies a plethora of signaling cascades among which both
pro-inflammatory and anti-inflammatory signaling cascades
are activated in a temporal resolution. Whereas stroke is
well known to activate pro-inflammatory signaling cascades
(Dirnagl et al., 1999), stroke itself is also known to induce
immunosuppression at later stages of the disease (Dirnagl
et al., 2007; Meisel and Meisel, 2011), affecting clinical
outcome of stroke patients. In light of this, we wondered
whether or not very delayed rPostC might affect stroke-
induced immunosuppression. Seven days after stroke, induction
of transient focal cerebral ischemia resulted in reduction of
leukocyte numbers in the blood when compared to non-
ischemic sham mice (Figure 7A). Induction of rPostC, however,
reversed the stroke-induced immunosuppression on day 7.
Further analysis revealed that rPostC predominantly affected
the restoration of both T-lymphocytes and B-lymphocytes
(Figures 7B–D). As such, rPostC increased the number of
B-lymphocytes and T-lymphocytes by 112.7% and by 50.7%,
respectively, when compared with ischemic controls, whereas
neutrophils were not affected by rPostC.
DISCUSSION
The present study underlines the importance of application
timing for hind limb rPostC in a mouse model of transient
focal cerebral ischemia. Acute neuroprotection as observed
after application of rPostC within 24 h (early rPostC) is
mediated via Hsp70 which in turn inhibits proteasomal
activation, yielding transient reduction of brain injury. On
the contrary, very delayed rPostC reverses peripheral post-
stroke immunosuppression which implies a modulation of the
extracellular milieu, stimulating neuroregenerative processes that
orchestrate sustained neurological recovery.
Direct ischemic post-conditioning has been shown to induce
both neuroprotection and neurological recovery in a variety
of experimental stroke models, including focal and global
cerebral ischemia (Burda et al., 2006; Gao et al., 2008;
Pignataro et al., 2008; Ren et al., 2008; Xing et al., 2008; Zhou
et al., 2011; Xie et al., 2013). Although the majority of work
published focuses on studying effects of ischemic cerebral
post-conditioning when applied within the first hours after
stroke onset, some data support the hypothesis that ischemic
post-conditioning might still be effective when applied as late
as 2 days after stroke onset. Indeed, previous work of our
own demonstrates that ischemic cerebral post-conditioning
is neuroprotective when applied within a critical period of
time of 24 h post-stroke (Doeppner et al., 2017). However,
ischemic direct post-conditioning fails to induce sustained
neuroprotection in this model of transient focal cerebral
ischemia. Rather, post-conditioning induces subtle modifications
of the extracellularmilieu which offers the possibility of successful
transplantation of NPCs, thus ensuring sustained neurological
recovery. Despite these promising results in the field of ischemic
post-conditioning of the brain, the concept of direct ischemic
post-conditioning provides little therapeutic benefit for an organ
such as the brain. As a matter of fact, direct ischemic post-
conditioning of the human brain, i.e., the induction of a second
subinjurious ischemic stimulus via transient obliteration of
the carotid arteries, is out of the question. Ischemic rPostC
therefore appears to be more attractive than common direct
ischemic post-conditioning of the brain from a clinical point of
view.
Not only in light of its potential therapeutic relevance but
also due to its practicability has ischemic rPostC been thoroughly
studied in a variety of experimental models. The latter implies
experimental studies on the kidney, the liver, the lung, the
heart, and the brain, to name but a few (Ren et al., 2011;
Hasseldam et al., 2013; Khan et al., 2015; Leung et al., 2015;
Li P. et al., 2015; Gao et al., 2016, 2017; Ramagiri and Taliyan,
2017a,b; Sandweiss et al., 2017; Kitagawa et al., 2018; Ren et al.,
2018). The mechanisms being involved are as diverse as the
models that have been applied. Yet, it appears to be evident
that well-known survival pathways as well as anti-oxidative
and anti-inflammatory cascades are modulated by rPostC in
this heterogeneous study group. In this sense, rPostC activates
survival signaling pathways such as Akt, JAK/STAT3, HO-
1, and GSK3beta, whereas the inhibition of at least some of
these aforementioned signaling pathways reverses the rPostC-
induced cellular protection (Li P. et al., 2015; Gao et al., 2016,
2017; Ramagiri and Taliyan, 2017a,b). As mentioned afore,
however, these studies cannot easily be compared between each
other as they significantly differ in their experimental models
chosen, which does not only affect the organ in question
but also the different timing chosen for the induction of
rPostC.
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FIGURE 7 | Very delayed rPostC reverses post-stroke peripheral immunosuppression. Flow cytometry analysis from blood samples was performed 7 days after
stroke induction in mice that had received rPostC 120 h after stroke or in control mice that had not received rPostC (non-rPostC). Sham animals underwent surgical
procedure for transient focal cerebral ischemia without inserting of the filament into the left middle cerebral artery. A quantitative analysis of leukocytes (A),
neutrophils (B), B-lymphocytes (C), and T-lymphocytes (D) was performed as described in the materials and methods section. ∗Significantly different from
non-rPostC, (p < 0.05). #Significantly different from Sham, (p < 0.05).
The precise cellular and molecular mechanisms that
are involved are neither known for pre-conditioning, per-
conditioning, or post-conditioning of the brain, may it be direct
conditioning or rPostC. Nevertheless, a great deal of evidence
suggests that these different concepts of conditioning share
some general signaling pathways (Zhao et al., 2012). Indeed,
early rPostC within 24 h after stroke induction yields reduction
of infarct volume, as has also been shown for direct post-
conditioning by our group before (Doeppner et al., 2017). This
data is in line with previous reports, showing that induction of
rPostC within the very first hours after stroke onset is associated
with reduction of acute brain injury (Ren et al., 2011; Hasseldam
et al., 2013; Li P. et al., 2015; Ramagiri and Taliyan, 2017b).
Of note, the reduction of infarct volume due to rPostC within
24 h as shown in the present study, exceeds rPostC intervals
as applied in the aforementioned studies significantly. In this
context, the acute neuroprotection in our experimental setting
is mediated via Hsp70 and the ubiquitin-proteasome-system
(UPS). Heat shock proteins such as Hsp70 are physiological
ligands of toll-like receptors (TLRs) such as TLR 2 and TLR4
(Vabulas et al., 2002; Asea, 2008; Tamura et al., 2012), which
in turn regulate pro-inflammatory signaling cascades among
which are NF-kB and the UPS (Gilmore and Wolenski, 2012;
Napetschnig and Wu, 2013). The role of Hsp70 in particular
under experimental settings of direct cerebral post-conditioning,
however, has been described by us recently (Doeppner et al.,
2017). It is therefore not surprising that rPostC involves a
similar mechanism which is herein shown for the first time, as
indicated by both reduced proteasomal activity and reversal of
rPostC-induced neuroprotection due to Hsp70 knockdown.
Induction of early rPostC does not yield sustained
neuroprotection during the observation period of 3 months
which is in line with previous data from our group,
demonstrating that direct cerebral post-conditioning induces
transient neuroprotection only (Doeppner et al., 2017). Likewise,
previous studies on rPostC after experimental stroke have
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focused on short time survival periods only as described afore
(Li P. et al., 2015; Gao et al., 2016, 2017; Ramagiri and Taliyan,
2017a,b). Whether or not neuroprotection observed in these
studies is transient only remains elusive. On the contrary, very
delayed rPostC induces sustained neuroprotection and improved
neurological recovery as indicated by a battery of various well
established behavioral tests (Doeppner et al., 2014a), which has
not been described elsewhere under these conditions. Improved
neurological recovery, however, is not a consequence of acute
neuroprotection which was not observed under these conditions
at all. Rather, very delayed rPostC induces pleiotropic effects
which orchestrate the aforementioned neurological recovery and
which has not been described in the literature elsewhere. This
is in contrast to previous data from our own, demonstrating
transient neuroprotection after direct ischemic post-conditioning
only (Doeppner et al., 2017). Nevertheless, survival periods in
that study were limited to 4 weeks only, showing no stimulation
of endogenous neuroregeneration which might explain the
discrepancy. As a matter of fact, very delayed rPostC modulates
peripheral post-stroke immune responses which has been
described before in a model of ischemic remote pre-conditioning
(Liu et al., 2016), leading in our present study to a reversal of
post-stroke immunosuppression. The latter is known to affect the
post-ischemic extracellular milieu (Doeppner et al., 2015), which
is observed in our study. The modification of the extracellular
milieu, in turn, favors a survival of endogenous endothelial and
neuronal progenitor cells (Doeppner et al., 2012a). Indeed, an
enhanced post-stroke endogenous angioneurogenesis after very
delayed rPostC helps orchestrate tissue regeneration via indirect
bystander effects of newly generated cells, albeit these new-born
cells are not integrated into residing neural networks. Rather,
the constant secretive activity of these new-born cells helps
boost post-stroke tissue regeneration. In line with this, recent
work from Ren et al. (2018) has shown that angiogenesis is
stimulated upon a combinative approach of both remote per-
conditioning and rPostC after stroke, which is contributed to
the Notch signaling pathway. Nevertheless, survival periods were
limited to 2 weeks only, giving no information regarding the
contribution of angiogenesis to neurological recovery in the long
run.
The concept of remote conditioning in general and the
concept of rPostC in particular are interesting concepts for
adjuvant treatment paradigms of different diseases. Indeed, first
clinical trials have been performed, suggesting possible beneficial
effects after remote conditioning (Zuo et al., 2015; Bei et al.,
2016; Hou et al., 2016; England et al., 2017; Wang et al., 2017;
Zhao et al., 2017; Zhou et al., 2017). Yet, the study concepts are
heterogeneous, including small study populations with special
medical conditions only. Leaving aside clinical trials on various
settings of renal malfunction (Bei et al., 2016; Zuo et al., 2015;
Zhou et al., 2017) as well as trials on chronic vessel diseases
of the brain (Hou et al., 2016; Wang et al., 2017; Zhao et al.,
2017), the RECAST study remains the only clinical trial where
rPostC has been applied as a therapeutic means to counter a
territorial ischemic stroke during the acute phase of the disease
(England et al., 2017). Of note, rPostC in the RECAST trial like
in the RESCUE BRAIN trial, which is currently recruiting (Pico
et al., 2016), treatment starts within 24 h post-stroke. According
to the findings of the present study, however, acute rPostC
results in transient neuroprotection, whereas very delayed rPostC
only yields a significant impact on the post-stroke neurological
outcome in the long-run. The choice for the optimal therapeutic
time frame of post-stroke rPostC in future clinical trials might
therefore be reconsidered. Consequently, further pre-clinical
studies on rPostC after stroke are urgently needed in order to
further validate the importance of very delayed rPostC, thus
avoiding negative and ill-designed future clinical trials.
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